Top

Published in:

01-01-2010 | Colorectal Cancer

Locally Recurrent Rectal Cancer: Prognostic Factors and Long-Term Outcomes of Multimodal Therapy

Authors: Fabio Pacelli, MD, Antonio P. Tortorelli, MD, Fausto Rosa, MD, Maurizio Bossola, MD, Alejandro M. Sanchez, MD, Valerio Papa, MD, Vincenzo Valentini, MD, Giovanni B. Doglietto, MD

Published in: Annals of Surgical Oncology | Issue 1/2010

Abstract

Background

Pelvic recurrent rectal cancer is still a challenging clinical problem, and patients generally have a dismal prognosis and a poor quality of life. Surgical resection represents the only potentially curative treatment; neoadjuvant treatments are presently being taken into consideration to increase the resectability rate and to improve long-term survival.

Methods

Among 157 patients observed with recurrent rectal cancer, a series of 58 patients who underwent surgical exploration with curative intent for isolated local recurrence at a single referral institution was retrospectively analyzed. Demographic, pathologic, and therapeutic factors were evaluated to assess long-term prognosis and local control.

Results

Forty-four (75.9%) of 58 patients underwent surgical resection. The overall 5-year survival rate for patients who underwent surgical resection was 54.2%, whereas none of the unresected patients lived 5 years (P < 0.001). Patients with R0 resection showed a statistically higher 5-year overall survival and local control rate (72.4 and 70.2%, respectively) compared to R1 patients (37.5 and 31.2%, respectively). At multivariate survival analysis, feasibility of a surgical resection and radicality of excision proved to be independent positive prognostic factors. In contrast, increased presalvage carcinoembryonic antigen serum levels, back pain at diagnosis, and an increasing degree of fixation of recurrent disease to the pelvic wall at preoperative computed tomographic scan were statistically significantly linked to decreased overall survival. Preoperative chemoradiation and radicality of the surgical excision independently influenced the local control among surgically resected patients.

Conclusions

Surgical resection still remains the most important therapeutic and prognostic factor for patients with locally recurrent rectal cancer. Multimodal treatments can be safely performed by an experienced team in referral tertiary centers and can result in a safer outcome, better local disease control, and even long-term survival in carefully selected patients.

Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in respectable rectal cancer. N Engl J Med. 1997;336:980–7.CrossRef

Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.CrossRefPubMed

Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.CrossRefPubMed

Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237:502–4.CrossRefPubMed

Heald RJ, Moran BJ, Ryall RDH, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133:894–9.CrossRefPubMed

Pacelli F, Di Giorgio A, Papa V, et al. Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer. Dis Colon Rectum. 2004;47:170–9.CrossRefPubMed

Mannaerts GHH, Rutten HJT, Martijn H, et al. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum. 2001;44:1749–58.CrossRefPubMed

Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005;48:929–37.CrossRefPubMed

Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum. 1996;39:730–6.CrossRefPubMed

10.

Valentini V, Morganti AG, De Franco A, et al. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer. 1999;86:2612–24.CrossRefPubMed

11.

Mohiuddin M, Marks GM, Lingareddy V, et al. Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;40:150–5.

12.

Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum. 1999;42:886–95.CrossRefPubMed

13.

Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer. 1995;75:939–52.CrossRefPubMed

14.

Pilipshen SJ, Heiweil M, Quan SHQ, et al. Patterns of pelvic recurrence following definitive resection of rectal cancer. Cancer. 1984;53:1354–62.CrossRefPubMed

15.

De Franco A, Vecchioli Scaldazza A, Celi G. Stadiazione mediante imaging delle recidive locali da neoplasia del retto. In: Basilico L, Valentini V, eds. Le recidive pelviche da neoplasia del retto. Diagnosi Stadiazione e Terapia. Vasto: Arte della Stampa-Cannarsa, 1998:36–41.

16.

Radice E, Dozois RR. Locally recurrent rectal cancer. Dig Surg 2001;18:355–62.CrossRefPubMed

17.

Palmer G, Martling A, Cedermark B, et al. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2006;15:3109–17.CrossRef

18.

Dresen RC, Gosens MJ, Martijn H, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol. 2008;15:1937–47.CrossRefPubMed

19.

Salo JC, Paty PB, Guillem J, et al. Surgical salvage of recurrent rectal carcinoma after curative resection: a ten-year experience. Ann Surg Oncol. 1999;6:171–7.CrossRefPubMed

20.

Wiig JN, Tveit KM, Poulsen JP, et al. Preoperative irradiation andsurgery for recurrent rectal cancer. Will inntraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol. 2002;62:207–13.CrossRefPubMed

21.

Caricato M, Borzomati D, Ausania F, et al. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol. 2006;32:126–32.CrossRefPubMed

22.

Vermaas M, Nuyttens JJME, Ferenschild FTJ, et al. Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients. Radiother Oncol. 2008;87:357–60.CrossRefPubMed

23.

Miller AR. Multidisciplinary management of recurrent colorectal cancer. Surg Oncol. 1998;7:209–21.CrossRefPubMed

24.

Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractioned chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006;64:1129–39.PubMed

25.

Haddock MG, Gunderson L, Nelson H, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys. 2001;49:1267–74.PubMed

26.

Glimelius B. Recurrent rectal cancer. The pre-irradiated primary tumour: can more radiotherapy be given? Colorectal Dis. 2003;5:501–3.CrossRefPubMed

27.

Wanebo HJ, Koness RJ, Vezeridis MP, et al. Pelvic resection of recurrent rectal cancer. Ann Surg. 1994;220:586–97.CrossRefPubMed

28.

Lopez-Koster F, Fazio VW, Vignali A, et al. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum. 2001;44:173–8.CrossRef

29.

Nagtegaal ID, van de Velde CJ, Marijnen CA, et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257–64.CrossRefPubMed

30.

West NP, Finan PJ, Anderin C, et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008;26:3517–22.CrossRefPubMed

31.

Holm T, Ljung A, Häggmark T, et al. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007;94:232–8.CrossRefPubMed

Title: Locally Recurrent Rectal Cancer: Prognostic Factors and Long-Term Outcomes of Multimodal Therapy
Authors: Fabio Pacelli, MD
Antonio P. Tortorelli, MD
Fausto Rosa, MD
Maurizio Bossola, MD
Alejandro M. Sanchez, MD
Valerio Papa, MD
Vincenzo Valentini, MD
Giovanni B. Doglietto, MD
Publication date: 01-01-2010
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 1/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-009-0737-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Locally Recurrent Rectal Cancer: Prognostic Factors and Long-Term Outcomes of Multimodal Therapy

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2010

Influence of Laparoscopic Gastrectomy on the Detection Rate of Free Gastric Cancer Cells in the Peritoneal Cavity

Surgery for Gastrointestinal Stromal Tumors of the Duodenum

Safety and Efficacy of Microwave Ablation of Hepatic Tumors: A Prospective Review of a 5-Year Experience

Thermal Sensitization Using Induced Oxidative Stress Decreases Tumor Growth in an In Vivo Model of Hyperthermic Intraperitoneal Perfusion

Reply to, “RET Germline Mutations in Codon 609 and MEN2A Phenotype: Are They All Created Equal?” by Machens and Dralle (ASO-2009-06-0652)

Lymph Node Metastases in Diffuse Malignant Peritoneal Mesothelioma